Revascularisation versus amputation for chronic limb-threatening ischaemia: a systematic review and meta-analysis of clinical outcomes and patient characteristics
Preprint
Abstract
Background: The relative merits of infrainguinal bypass and primary major lower limb amputation (MLLA) for chronic limb-threatening ischaemia (CLTI) remain uncertain, and the baseline profiles of patients selected for each strategy are poorly described. Methods: A systematic review and meta-analysis were undertaken in accordance with PRISMA 2020 and prospectively registered (PROSPERO: CRD42022356094). MEDLINE, Embase, CENTRAL, and CINAHL were searched from inception to March 2025. Prospective studies of adults with CLTI undergoing primary infrainguinal bypass or primary MLLA were eligible. Mortality, major adverse cardiovascular events (MACE) and subsequent amputation outcomes were synthesised using random-effects meta-analysis of proportions. Baseline comorbidity profiles were also extracted. Results: Twenty-seven studies involving 6,576 patients were included: 5,779 underwent infrainguinal bypass and 797 underwent MLLA. After bypass, pooled mortality was 3.7% at 30 days (95% CI 2.8%–4.9%, I² = 49.4%), 18.5% at 1 year (95% CI 15.6%–21.9%, I² = 62.3%), and 54.3% at 5 years (95% CI 50.5%–58.0%, I² = 0%). After MLLA, pooled mortality was 9.2% at 30 days (95% CI 4.1%–19.3%, I² = 73.5%), 28.5% at 1 year (95% CI 13.3%–51.0, I² = 70.8%), and 39.9% at 2 years (95% CI 0.3%–99.3, I² = 90.5%), although longer-term estimates were limited by sparse data and marked heterogeneity. Thirty-day MACE was 6.5% (95% CI 4.3%–9.7, I² = 63.5%) after bypass and 2.8% after MLLA (95% CI 0.1%–37.6%, I² = 0%). Early subsequent major amputation after bypass occurred in 3.9% of patients (95% CI 2.0%–7.7%, I² = 91.2%), rising to 16.2% at 1 year (95% CI 12.6%–20.5%, I² = 82.0%) and 33.3% at 3 years (95% CI 20.1%–49.8%, I² = 0%). Early re-amputation after MLLA occurred in 10.9% of patients (95% CI 4.5%–24.4%, I² = 40.3%). Baseline comorbidity burden was high in both groups, with substantial heterogeneity across studies. Conclusions: CLTI carries a poor prognosis regardless of treatment strategy. Infrainguinal bypass is associated with lower early mortality and better early limb preservation than primary MLLA, but long-term survival remains poor and later limb failure is common. Primary MLLA is not a low-risk alternative. Better contemporary comparative evidence utilising modern causal inference approaches is needed to support individualised decision-making.Keywords
This publication has 47 references indexed in Scilit:
- INTRAOPERATIVE TRANSIT-TIME FLOW AS A PREDICTOR OF FAILURE AFTER INFRAINGUINAL REVASCULARIZATION WITH HEPARIN-BONDED EXPANDED POLYTETRAFLUOROETHYLENE GRAFT.Annals of Vascular Surgery, 2024
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening IschemiaEuropean Journal of Vascular and Endovascular Surgery, 2019
- External Support of a Polytetrafluoroethylene Graft Improves Patency for Bypass to Below-Knee ArteriesAnnals of Vascular Surgery, 2013
- Healing of Ischaemic Tissue Lesions after Infrainguinal Bypass Surgery for Critical Leg IschaemiaEuropean Journal of Vascular and Endovascular Surgery, 2008
- Dacron or PTFE for Above-knee Femoropopliteal Bypass. A Multicenter Randomised StudyEuropean Journal of Vascular and Endovascular Surgery, 2007
- Risk‐scoring Method for Prediction of 30‐Day Postoperative Outcome after Infrainguinal Surgical Revascularization for Critical Lower‐limb Ischemia: a Finnvasc Registry StudyWorld Journal of Surgery, 2006
- Comparison of Carbon-impregnated and Standard ePTFE Prostheses in Extra-anatomical Anterior Tibial Artery Bypass: A Prospective Randomized Multicenter StudyEuropean Journal of Vascular and Endovascular Surgery, 2006
- Use of a Pneumatic Tourniquet Improves Outcome Following Trans-tibial AmputationEuropean Journal of Vascular and Endovascular Surgery, 2006
- Contemporary Series of Morbidity and Mortality after Lower Limb AmputationEuropean Journal of Vascular and Endovascular Surgery, 2005
- Amputation for occusive arterial diseaseInternational Orthopaedics, 1992